Lipoprotein apheresis in Germany – Still more commonly indicated than implemented. How can patients in need access therapy?-Reference-Cited by-同舟云学术

Lipoprotein apheresis in Germany – Still more commonly indicated than implemented. How can patients in need access therapy?

Published:2019-12 Issue: Volume:40 Page:23-29
ISSN:1567-5688
Container-title:Atherosclerosis Supplements
language:en
Short-container-title:Atherosclerosis Supplements

Author:

Heigl Franz,Pflederer Tobias,Klingel Reinhard,Hettich Reinhard,Lotz Norbert,Reeg Harduin,Schettler Volker J.J.,Roeseler Eberhard,Grützmacher Peter,Hohenstein Bernd,Julius Ulrich

Funder

European Group – International Society

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Reference35 articles.

1. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur Heart J,2017

2. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines;Grundy;J Am Coll Cardiol,2004

3. ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Stone;J Am Coll Cardiol,2013

4. ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European society of cardiology (ESC) and the European atherosclerosis society (EAS);Reiner;Eur Heart J,2011

5. 2016 European Guidelines on cardiovascular disease prevention in clinical practice

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effective exosomes reduction in hypercholesterinemic patients suffering from cardiovascular diseases by lipoprotein apheresis: Exosomes apheresis;Therapeutic Apheresis and Dialysis;2024-06-04

2. Lipoproteins, Cholesterol, and Atherosclerotic Cardiovascular Disease in East Asians and Europeans;Journal of Atherosclerosis and Thrombosis;2023-11-01

3. Lipidmanagement bei älteren CKD-Patienten;Geriatrische Nephrologie;2023

4. The development of lipoprotein apheresis in Saxony in the last years;Therapeutic Apheresis and Dialysis;2022-12

5. New Horizons: Revival of Lipoprotein (a) as a Risk Factor for Cardiovascular Disease;The Journal of Clinical Endocrinology & Metabolism;2022-09-15